Stellungnahme der AGO-Kommission Mamma zu – Zur Diskussion gestellt

• Literatur

• 1 Kühn T, Poortmans P. Comment on Giuliano A E et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer. JAMA 2011; 305: 569-573 Breast Care 2001; 6 154 - 156
• 2 Thomssen C, Grosse R, Kühn T. What Does It Take to Establish New Paradigms?. Breast Care 2011; 6: 83-84
• 3 Gerber B, Heintze K, Stubert J et al. Axillary lymph node dissection in early-stage invasive breast cancer: is it still standard today?. Breast Cancer Res Treat 27.04.2011; [Epub ahead of print]
• 4 Untch et al. St. Gallen-Konferenz 2011 zum primären Mammakarzinom – Meinungsbild deutscher Experten (Zürich 2011). Geburtsh Frauenheilk 2011; 71: 381-390
• 5 Moebus et al. Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study. J Clin Oncol 2010; 28 (Suppl. 17) 2874-80
• 6 Van Zee K et al. A Nomogram for Predicting the Likelihood of Additional Nodal Metastases in Breast Cancer Patients With a Positive Sentinel Node Biopsy. Ann Surg Oncol 2003; 10 (Suppl. 10) 1140-1151